|
시장보고서
상품코드
2078756
승모판막 질환 시장 규모, 점유율 및 성장 분석 : 치료법별, 유형별, 최종사용자별, 유통경로별, 지역별 - 업계 예측(2026-2033년)Mitral Valve Disease Market Size, Share, and Growth Analysis, By Treatment (Surgical Mitral Valve Repair, Transcatheter Mitral Valve Repair (MitraClip)), By Type, By End-User, By Distribution, By Region - Industry Forecast 2026-2033 |
||||||
세계의 승모판막 질환 시장 규모는 2024년에 18억 2,000만 달러로 평가되었고, 2025년 19억 6,000만 달러에서 2033년까지 35억 2,000만 달러로 성장하여 예측 기간(2026-2033년)에 CAGR 7.62%를 기록할 전망입니다.
세계 승모판막 질환 시장은 주로 고령화 사회에서 승모판 역류증 및 승모판 협착증의 높은 유병률에 힘입어 성장하고 있으며, 이러한 질환의 진단 및 치료를 목적으로 하는 혁신적인 의료기기 및 복원 기술에 의해 형성되고 있습니다. 경카테터 에지-투-에지 수복법 등의 발전은 치료 전략을 완전히 바꾸어 놓았으며, 저침습적 치료법으로의 대대적인 전환을 가져왔습니다. 이러한 추세는 입증된 유효성을 바탕으로, 효율적이고 저침습적인 시술에 대한 수요가 증가함에 따라 영향을 받고 있습니다. 경카테터 수복술의 도입이 확대됨에 따라, 이 시술의 적용 대상 환자층이 넓어지고 있으며, 병원 측은 임상의의 업무 효율을 높이고 시술 시간을 단축하기 위해 전용 수복실에 대한 투자를 진행하고 있습니다. 채용이 확대됨에 따라 의료의 질이 향상되고 비용도 절감되므로, 의료기기 설계 및 영상진단 기술에 대한 투자가 더욱 촉진되고 있으며, 이를 통해 시장의 성장이 지속적으로 뒷받침되고 환자의 예후도 개선되고 있습니다.
세계 승모판막 질환 시장의 성장 요인
세계 평균 수명의 연장에 따라 퇴행성 승모판막 질환에 걸릴 위험이 높은 인구가 증가하고 있으며, 이에 따라 임상적 인식이 높아지고 진단율도 상승하고 있습니다. 이러한 추세는 외과적 치료법과 경카테터 치료법 모두에 대한 수요를 확대시키고 있으며, 제조업체들은 제품 라인업을 확충하고 고령 환자의 요구에 부응하는 최첨단 기술에 대한 투자를 진행하고 있습니다. 그 결과, 이러한 상황은 치료 건수의 지속적인 증가와 치료법의 발전을 통해 시장 전체의 성장을 이끌고 있습니다. 또한, 의료 제도에서는 환자의 삶의 질(QOL)을 향상시키기 위한 조기 개입이 중시되고 있어, 시장에서 첨단 판막 치료 솔루션의 보급을 더욱 촉진하고 있습니다.
세계 승모판막 질환 시장의 제약 요인
세계 승모판막 질환 시장은 최첨단 승모판 시스템에 필요한 막대한 설비 투자에 더해, 전문적인 교육, 수술실 사용, 수술 후 관리와 관련된 비용으로 인해 큰 과제에 직면해 있습니다. 이러한 재정적 장벽은 특히 보험 환급 옵션이 제한적인 지역에서 많은 의료 서비스 제공업체들에게 걸림돌이 되어 도입률 둔화와 시장 침투율 저하로 이어지고 있습니다. 의료 기관은 더 선진적이긴 하지만 비용이 많이 드는 치료법보다는 비용 대비 효과가 높은 치료법을 선호하는 경향이 있으며, 이로 인해 신기술의 임상적 이점에도 불구하고 시장 전체의 성장을 저해하고 있습니다. 그 결과, 예산을 중시하는 병원은 경제 상황이 개선될 때까지 시설 업그레이드를 미루고, 기존의 수술 방식에 계속 의존하는 쪽을 선택할 가능성이 있습니다.
세계 승모판막 질환 시장 동향
세계 승모판막 질환 시장에서는 최소 침습 수술의 발전에 힘입어 패러다임 전환이 일어나고 있습니다. 카테터 기반 기술과 로봇 보조 기술의 혁신이 승모판막 치료에 혁명을 일으키고 있으며, 의료진은 개흉 수술 없이도 더 다양한 환자를 치료할 수 있게 되었습니다. 하이브리드 수술실 도입으로 수술 효율이 향상되고 있는 한편, 임상의들은 경피적 복원 및 치환술을 점점 더 적극적으로 채택하고 있으며, 그 결과 환자의 회복이 빨라지고 만족도도 높아지고 있습니다. 이러한 변화하는 시장 상황이 경카테터 전달 기기 수요를 뒷받침하고 있으며, 각 제조업체는 플랫폼의 범용성에 주력하는 한편, 기존 시장과 신흥 시장 모두에서 기회를 최대한 활용하기 위해 전 세계 유통 채널을 확대되고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 승모판막 질환 시장 규모 : 치료별
세계의 승모판막 질환 시장 규모 : 유형별
세계의 승모판막 질환 시장 규모 : 최종사용자별
세계의 승모판막 질환 시장 규모 : 유통별
세계의 승모판막 질환 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
LSH 26.07.09Global Mitral Valve Disease Market size was valued at USD 1.82 Billion in 2024 and is poised to grow from USD 1.96 Billion in 2025 to USD 3.52 Billion by 2033, growing at a CAGR of 7.62% during the forecast period (2026-2033).
The global mitral valve disease market is shaped by innovative devices and repair technologies aimed at diagnosing and treating mitral regurgitation and mitral stenosis, primarily driven by the high prevalence of these conditions among the aging population. Advancements such as transcatheter edge-to-edge repair have transformed treatment strategies, resulting in a significant shift towards less invasive solutions. This trend is influenced by growing demand for efficient, minimally invasive procedures, underpinned by their demonstrated efficacy. Increased adoption of transcatheter repair methods is expanding the eligible patient population, prompting hospitals to invest in specialized repair suites that enhance clinician performance and reduce procedure times. As adoption rises, both care quality improves and costs decrease, prompting more investment in device design and imaging technologies, thereby continuously propelling market growth and enhancing patient outcomes.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mitral Valve Disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Mitral Valve Disease Market Segments Analysis
Global mitral valve disease market is segmented by treatment, type, end-user, distribution and region. Based on treatment, the market is segmented into Surgical Mitral Valve Repair, Transcatheter Mitral Valve Repair (MitraClip), Surgical Mitral Valve Replacement and Transcatheter Mitral Valve Replacement (TMVR). Based on type, the market is segmented into Mitral Valve Regurgitation (MR) and Mitral Valve Stenosis. Based on end-user, the market is segmented into Cardiac Surgery Centers and Hospitals. Based on distribution, the market is segmented into Direct Sales and Distributors. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Mitral Valve Disease Market
The rise in global life expectancy has resulted in a larger population susceptible to degenerative mitral valve diseases, which enhances clinical recognition and increases diagnosis rates. This trend has generated a greater demand for both surgical and transcatheter treatment methods, prompting manufacturers to broaden their product ranges and invest in cutting-edge technologies tailored to the needs of older patients. Consequently, this scenario drives overall market growth through continuous volume increase and advancements in therapy. Furthermore, healthcare systems are emphasizing early interventions to enhance patient quality of life, further promoting the acceptance of sophisticated valve solutions in the market.
Restraints in the Global Mitral Valve Disease Market
The Global Mitral Valve Disease market faces significant challenges due to the high capital investment needed for state-of-the-art mitral valve systems and the associated costs of specialized training, operating room usage, and postoperative care. These financial hurdles create barriers for many healthcare providers, particularly in areas with limited reimbursement options, leading to slower adoption rates and lower market penetration. Institutions often favor cost-effective treatments over more advanced but expensive alternatives, which hampers overall market growth despite the clinical advantages of newer technologies. As a result, budget-conscious hospitals may choose to delay upgrades, continuing to rely on traditional surgical procedures until the economic conditions improve.
Market Trends of the Global Mitral Valve Disease Market
The Global Mitral Valve Disease market is experiencing a paradigm shift driven by advancements in minimally invasive procedures. Innovations in catheter-based techniques and robotic assistance are revolutionizing mitral valve interventions, allowing healthcare providers to treat a wider range of patients without the need for open-heart surgery. The adoption of hybrid operating rooms is enhancing surgical efficiency, while clinicians increasingly embrace percutaneous repair and replacement options, resulting in faster patient recovery and heightened satisfaction. This evolving landscape is propelling demand for transcatheter delivery devices, prompting manufacturers to focus on platform versatility and expand their global distribution channels to capitalize on opportunities in both established and emerging markets.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Mitral Valve Disease Market Size by Treatment & CAGR (2026-2033)
- Market Overview
- Surgical Mitral Valve Repair
- Transcatheter Mitral Valve Repair (MitraClip)
- Surgical Mitral Valve Replacement
- Transcatheter Mitral Valve Replacement (TMVR)
Global Mitral Valve Disease Market Size by Type & CAGR (2026-2033)
- Market Overview
- Mitral Valve Regurgitation (MR)
- Mitral Valve Stenosis
Global Mitral Valve Disease Market Size by End-User & CAGR (2026-2033)
- Market Overview
- Cardiac Surgery Centers
- Hospitals
Global Mitral Valve Disease Market Size by Distribution & CAGR (2026-2033)
- Market Overview
- Direct Sales
- Distributors
Global Mitral Valve Disease Market Size & CAGR (2026-2033)
- North America (Treatment, Type, End-User, Distribution)
- US
- Canada
- Europe (Treatment, Type, End-User, Distribution)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Treatment, Type, End-User, Distribution)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Treatment, Type, End-User, Distribution)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Treatment, Type, End-User, Distribution)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Abbott Laboratories (MitraClip)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Edwards Lifesciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LivaNova plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- 4Tech Cardio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tendyne Holdings (Abbott)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Neovasc Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CardiAQ Valve Technologies (Edwards)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mitralign
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NovaBay Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- JenaValve Technology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Annalign Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Millipede (Boston Scientific)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Polares Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HighLife SAS
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CardioValve
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Trisol Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- TenAx Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardiac Dimensions
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
